JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giri, J. G.
Right arrow Articles by Horuk, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giri, J. G.
Right arrow Articles by Horuk, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 265, Issue 29, 17416-17419, 10, 1990

Identification of soluble interleukin-1 binding protein in cell-free supernatants. Evidence for soluble interleukin-1 receptor

JG Giri, RC Newton and R Horuk
Medical Products Division, E. I. Du Pont De Nemours & Co., Glenolden Laboratory, Pennsylvania 19036.

This study describes the identification and characterization of a soluble interleukin-1 (IL-1) binding protein in the conditioned media from Raji human B-lymphoma cells. The soluble IL-1 binding material was isolated by IL-1 affinity chromatography, and treatment with trypsin decreased its ability to bind to IL-1 demonstrating its protein nature. The soluble IL-1 binding protein was specific for IL-1 and was able to discriminate between Il-1 alpha and IL-1 beta in a manner analogous to the membrane-bound Raji IL-1 receptor. The specificity of the IL-1 binding protein was further established in two ways. 1) Cell-free supernatants from Raji "receptor-negative" cells did not contain any IL- 1 binding protein, thus ruling out nonspecific interactions between IL- 1 and a serum or other protein present in the conditioned medium; and 2) the soluble binding protein inhibited IL-1 binding to Raji cells in a dose-dependent manner. Scatchard analysis of IL-1 beta binding showed the dissociation constant (KD) to be 5.1 nM for the soluble IL-1 binding protein compared with 0.8 nM for the membrane-bound IL-1 receptor. Gel chromatography of the soluble binding protein yielded a major peak of IL-1 binding activity with a molecular mass of 35-45 kDa. The characteristics of the soluble IL-1 binding protein described above are consistent with those of the extracellular binding domain of the membrane-bound Raji IL-1 receptor.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
X. Zhang, M. Kohli, Q. Zhou, D. T. Graves, and S. Amar
Short- and Long-Term Effects of IL-1 and TNF Antagonists on Periodontal Wound Healing
J. Immunol., September 1, 2004; 173(5): 3514 - 3523.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. Boucher, A. Kharfi, M. Al-Akoum, P. Bossu, and A. Akoum
Cycle-Dependent Expression of Interleukin-1 Receptor Type II in the Human Endometrium
Biol Reprod, September 1, 2001; 65(3): 890 - 898.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. L. Cubitt, R. N. Lausch, and J. E. Oakes
Synthesis of Type II Interleukin-1 Receptors by Human Corneal Epithelial Cells but not by Keratocytes
Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 701 - 704.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
D. Neumann, C. Kollewe, M. U. Martin, and D. Boraschi
The Membrane Form of the Type II IL-1 Receptor Accounts for Inhibitory Function
J. Immunol., September 15, 2000; 165(6): 3350 - 3357.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
K F Chung and P J Barnes
Cytokines in asthma
Thorax, September 1, 1999; 54(9): 825 - 857.
[Full Text]


Home page
J. Immunol.Home page
G. Penton-Rol, S. Orlando, N. Polentarutti, S. Bernasconi, M. Muzio, M. Introna, and A. Mantovani
Bacterial Lipopolysaccharide Causes Rapid Shedding, Followed by Inhibition of mRNA Expression, of the IL-1 Type II Receptor, with Concomitant Up-Regulation of the Type I Receptor and Induction of Incompletely Spliced Transcripts
J. Immunol., March 1, 1999; 162(5): 2931 - 2938.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Reikerstorfer, H. Holz, H. G. Stunnenberg, and M. Busslinger
Low Affinity Binding of Interleukin-1[IMAGE] and Intracellular Signaling via NF-[IMAGE]B Identify Fit-1 as a Distant Member of the Interleukin-1 Receptor Family
J. Biol. Chem., July 28, 1995; 270(30): 17645 - 17648.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
F Colotta, F Re, M Muzio, R Bertini, N Polentarutti, M Sironi, J. Giri, S. Dower, J. Sims, and A Mantovani
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
Science, July 23, 1993; 261(5120): 472 - 475.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.